Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures

EXPERT OPINION ON PHARMACOTHERAPY

Rektor, I, 2013: Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures. EXPERT OPINION ON PHARMACOTHERAPY 14(2), p. 225 - 235, doi: 10.1517/14656566.2013.754883

Research Groups:

• CF: Multimodal and Functional Imaging Laboratory
• Multi-modal and Functional Neuroimaging - Ivan Rektor

CEITEC authors:

• Prof. Ivan Rektor